🔗 Share this article

A shadow market for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Experimental Drug Acquiring Popularity Via Social Media

Retatrutide, which remains in clinical trials, is being advertised by online personalities for its supposed weight-reducing effects. Viewers are encouraged to contact these profiles privately for supplier links, while also obtaining discount codes.

Active Trade on Social Networks

Separately, a robust market exists on messaging services, where groups with numerous of participants share comparison photos, injection guides and claims of next-day UK delivery. Vendors promote the drug there before redirecting customers to WhatsApp for transactions.

Understanding Retatrutide

This medication is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.

Healthcare Experts Voice Concerns

Nevertheless, doctors and chemists have warned that the distribution of what remains an unapproved drug in the UK is a cause for concern and could lead to users administering products of unknown origin.

Some professionals said the demand for the experimental drug could be connected to the rising price of approved slimming products such as Mounjaro.

Legal Position and Implementation

Marketing retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still violate medicines, advertising, and customer laws, potentially leading to penalties, prosecution or prison.

Platform Response and Content Elimination

According to the social media company, the platform has taken down problematic content and banned associated keywords and query recommendations. The company stated it was dedicated to keeping the service secure and allocating resources in strengthening enforcement strategies.

Online Trading Activities

Investigations also found communities with up to 9,000 members selling retatrutide using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately displays channels with thousands of members, filled with photos of weight loss, glowing testimonials and step-by-step instructions for mixing or administering at residence.

After moments of entering one community, a vendor shared contact information, where most purchases take place. The seller sent an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one asked about weight, health issues or past usage.

Product Details and Costs

Within these groups, messages show black plastic packages with postal service stickers, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at home with sterile water, or ready-to-use pens usually sold at 160 pounds for 20mg. When questioned how much time a injector should be used, vendors give conflicting responses ranging from a few weeks to “depends on your body”.

Service Moderation and Security Actions

A representative for the messaging service stated it actively monitored harmful content on its service including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are administering materials they can’t verify. Even if the science behind this drug is sound, these digital products may not include what they claim,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to recent cost increases for approved weight-loss medications such as Mounjaro. “With costs increasing, individuals are turning to social media. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the conditions they were made in was sterile,” she explained.

Her staff has already encountered individuals harmed by personal administration from unconfirmed sources. “We recognize the disappointment, but buying from Telegram or communication platforms is taking chances with your well-being,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may subject users to potentially serious medical dangers”.